Published in AIDS Weekly, April 21st, 1997
PolyHeme is a blood substitute. The pivotal trials, the first Phase III studies to include direct replacement of blood in large volumes, mark a milestone in medicine's search for an oxygen-carrying blood substitute, the company said.
Under the Phase III protocol cleared by the FDA, surgical patients are infused with six units of PolyHeme, Northfield's proprietary blood substitute. The six-unit level (3 liters containing 300 grams of hemoglobin) represents approximately 60 percent of an...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.